+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Personalized Psychiatry Market Outlook 2026-2034

  • PDF Icon

    Report

  • 160 Pages
  • November 2026
  • Region: Global
  • OG Analysis
  • ID: 6242024
UP TO OFF until Jan 01st 2027
The Personalized Psychiatry Market is estimated at USD 6.0 billion in 2026 and is projected to reach USD 13.2 billion by 2034, growing at a CAGR of 10.4% during 2026-2034.

Market Overview

Personalized psychiatry concerns clinical and genetic assessment workflows and related research, without assuming that every test can reliably predict treatment response. Psychiatric care research explores individual treatment differences. Genetic and clinical data inform different assessment questions.

Predictive validity and access constrain clinical use. Carefully validated workflows support focused research. National clinical and testing pathways differ. Buyers compare software capabilities with integration requirements and support arrangements. Subscription pricing alone does not capture migration, governance and continuing operating costs. Deployment choices depend on data, security and application constraints. Large organizations and smaller users often require different implementation models and service depth. Buyers need evidence of interoperability and reliable operation. Documentation and clearly defined responsibilities support consistent delivery across complex environments. Contract scope and support arrangements affect purchasing. Buyers assess service levels, data access and continuing administration alongside the core platform functionality.

Key Takeaways

  • Demand drivers: Psychiatric care research explores individual treatment differences. Adoption can slow when organizations lack reliable data, process ownership or the skills needed to operate the solution.
  • Technology and performance: Genetic and clinical data inform different assessment questions. Connectors and configuration need to remain dependable as underlying applications and operating requirements change.
  • Challenges and economics: Predictive validity and access constrain clinical use. Migration, customization, administration and support influence the practical economics of deployment and expansion.
  • Commercial opportunities: Carefully validated workflows support focused research. Focused use cases can create repeatable demand. Implementation expertise and manageable operating requirements help buyers move from evaluation into sustained use.
  • Geographic considerations: National clinical and testing pathways differ. Digital maturity and local operating requirements differ across markets. Data governance, implementation capacity and customer support affect regional routes to market.
  • Application requirements: Personalized psychiatry concerns clinical and genetic assessment workflows and related research, without assuming that every test can reliably predict treatment response. Deployment choices depend on data, security and application constraints. Large organizations and smaller users often require different implementation models and service depth.
  • Quality and qualification: Buyers need evidence of interoperability and reliable operation. Documentation and clearly defined responsibilities support consistent delivery across complex environments. Genetic and clinical data inform different assessment questions.
  • Purchasing and delivery: Providers distinguish research tools from proven treatment-selection benefits. Contract scope and support arrangements affect purchasing. Buyers assess service levels, data access and continuing administration alongside the core platform functionality. Deployment choices depend on data, security and application constraints. Large organizations and smaller users often require different implementation models and service depth. Investment requires a clear workflow benefit. Adoption can slow when organizations lack reliable data, process ownership or the skills needed to operate the solution. Integration quality is central to usable performance. Connectors and configuration need to remain dependable as underlying applications and operating requirements change.
  • Competitive positioning: Myriad Genetics, Genomind and OneOme are among the companies covered. The analysis distinguishes relevant product, technology and channel roles, with emphasis on application fit, supply capabilities and customer support.
  • Outlook priorities: The personalized psychiatry outlook depends on the interaction of end-use demand, product qualification and commercially viable delivery. Carefully validated workflows support focused research. National clinical and testing pathways differ.

Competitive Landscape

Testing, clinical-data analysis and enabling genomic tools occupy different roles. Product inclusion is not evidence that a test reliably selects a psychiatric medicine for every patient. Competitive assessment compares relevant portfolios, product qualification, customer support and commercial delivery. Product-level evidence and current availability determine the applicable supplier role. The company coverage is representative and unranked; diversified corporate revenues and adjacent categories are not assigned wholly to this market. Clear value-chain boundaries support meaningful comparison of supply capability, routes to market and ongoing customer relationships.

Companies Mentioned

  • Myriad Genetics
  • Genomind
  • OneOme
  • Tempus
  • Castle Biosciences
  • Labcorp
  • Quest Diagnostics
  • Thermo Fisher Scientific
  • QIAGEN
  • Illumina
  • SOPHiA GENETICS
  • DNAnexus

Personalized Psychiatry Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Personalized Psychiatry Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analysed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across the report’s covered markets.

Countries Covered

  • North America - Personalized Psychiatry Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Personalized Psychiatry Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • BeNeLux
    • Russia
    • Sweden

  • Asia-Pacific - Personalized Psychiatry Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Personalized Psychiatry Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Personalized Psychiatry Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru
* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Personalized Psychiatry value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

  • What are the current market size and outlook across the covered markets?
  • Which product and customer categories offer the most relevant opportunities?
  • How do supply conditions, pricing and competitive strategies affect market development?
  • Which risks and practical investment considerations should decision makers evaluate?

Your Key Takeaways from the Personalized Psychiatry Market Report

  • Global Personalized Psychiatry Market size and growth projections (CAGR), 2026-2034
  • Impact of geopolitical developments on Personalized Psychiatry trade, costs, and supply chains
  • Personalized Psychiatry Market size, share, and outlook across the 5 regions and country/subregional markets listed above, 2026-2034
  • Personalized Psychiatry Market size, CAGR, and market share of key products, applications, and end-user verticals, 2026-2034
  • Short- and long-term Personalized Psychiatry Market trends, drivers, restraints, and opportunities
  • Porter’s Five Forces analysis, technological developments, and Personalized Psychiatry supply chain analysis
  • Personalized Psychiatry trade analysis, Personalized Psychiatry Market price analysis, and Personalized Psychiatry supply/demand dynamics
  • Company profiles covering business overview, key strategies, financial information where available, and relevant products
  • Latest Personalized Psychiatry Market news and developments

This product will be delivered within 1-3 business days.

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Global Personalized Psychiatry Market Summary, 2026
2.1 Personalized Psychiatry Industry Overview
2.1.1 Global Personalized Psychiatry Market Revenues (In US$ billion)
2.2 Personalized Psychiatry Market Scope
2.3 Research Methodology
3. Personalized Psychiatry Market Insights, 2025-2035
3.1 Personalized Psychiatry Market Drivers
3.2 Personalized Psychiatry Market Restraints
3.3 Personalized Psychiatry Market Opportunities
3.4 Personalized Psychiatry Market Challenges
3.5 Tariff Impact on Global Personalized Psychiatry Supply Chain Patterns
4. Personalized Psychiatry Market Analytics
4.1 Personalized Psychiatry Market Size and Share, Key Product, 2026 Vs 2035
4.2 Personalized Psychiatry Market Size and Share, Dominant Application, 2026 Vs 2035
4.3 Personalized Psychiatry Market Size and Share, Leading Sales Channel, 2026 Vs 2035
4.4 Personalized Psychiatry Market Size and Share, High Growth Countries, 2026 Vs 2035
4.5 Five Forces Analysis for Global Personalized Psychiatry Market
4.5.1 Personalized Psychiatry Industry Attractiveness Index, 2026
4.5.2 Personalized Psychiatry Supplier Intelligence
4.5.3 Personalized Psychiatry Buyer Intelligence
4.5.4 Personalized Psychiatry Competition Intelligence
4.5.5 Personalized Psychiatry Product Alternatives and Substitutes Intelligence
4.5.6 Personalized Psychiatry Market Entry Intelligence
5. Global Personalized Psychiatry Market Statistics - Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2035
5.1 World Personalized Psychiatry Market Size, Potential and Growth Outlook, 2025-2035
5.1 Global Personalized Psychiatry Sales Outlook and CAGR Growth By Product, 2025-2035
5.2 Global Personalized Psychiatry Sales Outlook and CAGR Growth By Application, 2025-2035
5.3 Global Personalized Psychiatry Sales Outlook and CAGR Growth By Sales Channel, 2025-2035
5.4 Global Personalized Psychiatry Market Sales Outlook and Growth by Region, 2025-2035
6. Asia-Pacific Personalized Psychiatry Industry Statistics - Market Size, Share, Competition and Outlook
6.1 Asia-Pacific Personalized Psychiatry Market Insights, 2026
6.2 Asia-Pacific Personalized Psychiatry Market Revenue Forecast By Product, 2025-2035
6.3 Asia-Pacific Personalized Psychiatry Market Revenue Forecast By Application, 2025-2035
6.4 Asia-Pacific Personalized Psychiatry Market Revenue Forecast By Sales Channel, 2025-2035
6.5 Asia-Pacific Personalized Psychiatry Market Revenue Forecast by Country, 2025-2035
6.5.1 China Personalized Psychiatry Market Size, Opportunities, Growth 2025-2035
6.5.2 India Personalized Psychiatry Market Size, Opportunities, Growth 2025-2035
6.5.3 Japan Personalized Psychiatry Market Size, Opportunities, Growth 2025-2035
6.5.4 Australia Personalized Psychiatry Market Size, Opportunities, Growth 2025-2035
7. Europe Personalized Psychiatry Market Data, Penetration, and Business Prospects to 2035
7.1 Europe Personalized Psychiatry Market Key Findings, 2026
7.2 Europe Personalized Psychiatry Market Size and Percentage Breakdown By Product, 2025-2035
7.3 Europe Personalized Psychiatry Market Size and Percentage Breakdown By Application, 2025-2035
7.4 Europe Personalized Psychiatry Market Size and Percentage Breakdown By Sales Channel, 2025-2035
7.5 Europe Personalized Psychiatry Market Size and Percentage Breakdown by Country, 2025-2035
7.5.1 Germany Personalized Psychiatry Market Size, Trends, Growth Outlook to 2035
7.5.2 United Kingdom Personalized Psychiatry Market Size, Trends, Growth Outlook to 2035
7.5.2 France Personalized Psychiatry Market Size, Trends, Growth Outlook to 2035
7.5.2 Italy Personalized Psychiatry Market Size, Trends, Growth Outlook to 2035
7.5.2 Spain Personalized Psychiatry Market Size, Trends, Growth Outlook to 2035
8. North America Personalized Psychiatry Market Size, Growth Trends, and Future Prospects to 2035
8.1 North America Snapshot, 2026
8.2 North America Personalized Psychiatry Market Analysis and Outlook By Product, 2025-2035
8.3 North America Personalized Psychiatry Market Analysis and Outlook By Application, 2025-2035
8.4 North America Personalized Psychiatry Market Analysis and Outlook By Sales Channel, 2025-2035
8.5 North America Personalized Psychiatry Market Analysis and Outlook by Country, 2025-2035
8.5.1 United States Personalized Psychiatry Market Size, Share, Growth Trends and Forecast, 2025-2035
8.5.1 Canada Personalized Psychiatry Market Size, Share, Growth Trends and Forecast, 2025-2035
8.5.1 Mexico Personalized Psychiatry Market Size, Share, Growth Trends and Forecast, 2025-2035
9. South and Central America Personalized Psychiatry Market Drivers, Challenges, and Future Prospects
9.1 Latin America Personalized Psychiatry Market Data, 2026
9.2 Latin America Personalized Psychiatry Market Future By Product, 2025-2035
9.3 Latin America Personalized Psychiatry Market Future By Application, 2025-2035
9.4 Latin America Personalized Psychiatry Market Future By Sales Channel, 2025-2035
9.5 Latin America Personalized Psychiatry Market Future by Country, 2025-2035
9.5.1 Brazil Personalized Psychiatry Market Size, Share and Opportunities to 2035
9.5.2 Argentina Personalized Psychiatry Market Size, Share and Opportunities to 2035
10. Middle East Africa Personalized Psychiatry Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2026
10.2 Middle East Africa Personalized Psychiatry Market Statistics By Product, 2025-2035
10.3 Middle East Africa Personalized Psychiatry Market Statistics By Application, 2025-2035
10.4 Middle East Africa Personalized Psychiatry Market Statistics By Sales Channel, 2025-2035
10.5 Middle East Africa Personalized Psychiatry Market Statistics by Country, 2025-2035
10.5.1 Middle East Personalized Psychiatry Market Value, Trends, Growth Forecasts to 2035
10.5.2 Africa Personalized Psychiatry Market Value, Trends, Growth Forecasts to 2035
11. Personalized Psychiatry Market Structure and Competitive Landscape
11.1 Key Companies in Personalized Psychiatry Industry
11.2 Personalized Psychiatry Business Overview
11.3 Personalized Psychiatry Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis
12. Appendix
12.1 Global Personalized Psychiatry Market Volume (Tons)
12.1 Global Personalized Psychiatry Trade and Price Analysis
12.2 Personalized Psychiatry Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Personalized Psychiatry Industry Report Sources and Methodology

Companies Mentioned

  • Myriad Genetics
  • Genomind
  • OneOme
  • Tempus
  • Castle Biosciences
  • Labcorp
  • Quest Diagnostics
  • Thermo Fisher Scientific
  • QIAGEN
  • Illumina
  • SOPHiA GENETICS
  • DNAnexus

Table Information